Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software
New Interoperability Is Designed to Streamline Clinical Workflow
Mountain View, Calif.—Nov. 30, 2016—Omnicell, Inc. (NASDAQ: OMCL) and Hospira, a Pfizer (NYSE:PFE) company and a leading provider of infusion technologies, today announced they have achieved initial interoperability between Omnicell's new Performance Center and Hospira's smart infusion pumps.
Users of the Performance Center, an integrated services and software platform designed to drive improved pharmacy operations through long-term partnerships with customers, can now directly access Hospira MedNet Safety Software, which can help enhance patient safety through the management and enforcement of drug-specific dosing limits on IV medications. The ability to directly connect with Hospira MedNet from Omnicell's Performance Center enables streamlined access to drug libraries and IV administration reporting for nurses and pharmacists at hospitals utilizing both technologies.
In addition, Omnicell and Hospira announced that the two companies are collaborating to further system interoperability, with the goal of delivering the greatest possible value to the hundreds of hospitals that utilize Omnicell's medication management solutions and Hospira's infusion technologies.
"This initial step in integrating Hospira MedNet Safety Software and the Omnicell Performance Center is an important advancement toward greater interoperability between two innovative technologies," said Julie Sawyer Montgomery, president, Hospira Infusion Systems. "We are excited to be collaborating with Omnicell towards interoperability opportunities to support healthcare organizations seeking measurable improvement in clinician workflow, patient satisfaction and medication management."
"Many of our customers have expressed a desire for a central location to review clinical data from disparate pharmacy systems," said Nhat Ngo, executive vice president, Strategy and Business Development, Omnicell. "Working closely with Hospira to provide such a solution for pharmacy through the Performance Center is an important step that will bolster what we can offer to our customers."
For more information, please visit the Omnicell booth (#420) and Hospira booth (#243) at the 2016 ASHP Midyear Clinical Meeting and Exhibition at the Mandalay Bay Convention Center in Las Vegas from December 5–7.
Hospira, a Pfizer company, is a leading provider of infusion technologies. The company's focused infusion systems portfolio features I.V. solutions, proven, innovative smart pumps, and pain management and safety software technology designed to help meet clinical, safety and workflow goals. Learn more at www.hospira.com.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.
The Omnicell SureMed® solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served via Omnicell's sales channels and our solutions enable them to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
For more information, contact:
Next Step Communications